RESUMO
Among different Candida species triggering vaginal candidiasis, Candida albicans is the most predominant yeast. It is commonly treated using azole drugs such as Tioconazole (TIO) and Econazole (ECO). However, their low water solubility may affect their therapeutic efficiency. Therefore, the aim of this research was to produce a novel chitosan nanocapsule based delivery system comprising of TIO or ECO and to study their suitability in vaginal application. These systems were characterized by their physicochemical properties, encapsulation efficiency, in vitro release, storage stability, cytotoxicity, and in vitro biological activity. Both nanocapsules loaded with TIO (average hydrodynamic size of 146.8 ± 0.8 nm, zeta potential of +24.7 ± 1.1 mV) or ECO (average hydrodynamic size of 127.1 ± 1.5 nm, zeta potential of +33.0 ± 1.0 mV) showed excellent association efficiency (99% for TIO and 87% for ECO). The analysis of size, polydispersity index, and zeta potential of the systems at 4, 25, and 37 °C (over a period of two months) showed the stability of the systems. Finally, the developed nanosystems presented fungicidal activity against C. albicans at non-toxic concentrations (studied on model human skin cells). The results obtained from this study are the first step in the development of a pharmaceutical dosage form suitable for the treatment of vaginal candidiasis.
Assuntos
Antifúngicos/administração & dosagem , Quitosana/química , Portadores de Fármacos/química , Nanopartículas/química , Antifúngicos/química , Candida albicans/efeitos dos fármacos , Fenômenos Químicos , Sistemas de Liberação de Medicamentos , Liberação Controlada de Fármacos , Estabilidade de Medicamentos , Econazol/administração & dosagem , Econazol/química , Imidazóis/administração & dosagem , Imidazóis/química , Testes de Sensibilidade Microbiana , Estrutura Molecular , Nanocápsulas/química , Nanopartículas/ultraestruturaRESUMO
Azole drugs such as econazole, are active on Mycobacterium tuberculosis and Mycobacterium smegmatis ; however, the identification of their target(s) is still pending. It has been reported that mutations in the non-essential system mmpL5-mmpS5 conferred resistance to econazole in M. tuberculosis . We herein report that an azole-resistant mutant screen in M. smegmatis rendered mutations in rshA, encoding a non-essential anti-sigma H protein.
RESUMO
La piel es un órgano apropiado para administrar principios activos con el fin de obtener efectos locales o sistémicos. Las formulaciones de uso tópico más comunes son: lociones, emulsiones, suspensiones, cremas, pomadas; las cuales deben reunir determinadas condiciones para ser aplicadas sobre la piel. El objetivo del presente trabajo es seleccionar una emulsión preparada con la técnica de formación de cristales líquidos compuesta de ácido esteárico, vaselina líquida, trietanolamina, propilparabeno, metilparabeno y agua, a la que se le incorpora un ingrediente farmacéutico activo liposoluble: econazol. El econazol, principio activo cuya vía de administración es la tópica y su acción es local, es una sustancia soluble en aceites, que se aloja en la fracción liposoluble de los cristales líquidos y en la fase interna de la emulsión sin que se modifique el perfil reológico ni la estabilidad de los sistemas. Se estudió además del HLB y de sus comportamientos reológicos, la presencia de cristales líquidos con luz polarizada, la existencia de gotas secundarias con luz común y la estabilidad de los sistemas por centrifugación y estrés térmico a temperaturas de 40 ºC. Los valores obtenidos en los estudios realizados, demostraron que la emulsión lograda presenta un perfil reológico y las condiciones de estabilidad adecuadas para ser utilizada como crema medicinal.
The skin is the appropiate organ to administrate active principles in orden to obtain local or systemic effects. Formulations for topical use most common are: lotions, emulsions, suspensions, creams, ointments, which must gather certain conditions to be applied to the skin. In this work, the objective is to select an emulsion prepared by a technique of liquid crystals formation composed by stearic acid, mineral oil, triethanolamine, propylparaben, methylparaben and water. To this formula we incorporated a pharmaceutical active liposoluble ingredient: econazole. Econazole, a principle active with topical administration and local action, is a substance soluble in oils, which stays in the liposoluble fraction of the liquid crystals and in their internal phase of the emulsion without modifying their rheological profile not even the stability of systems. Besides the HLB of the systems and their rheological behaviour we also study the presence of liquid crystals with polarized light, the existence of secondary drops with common light and systems stability by centrifugation, thermal stress and temperatures of 40 °C. The values obtained from the studies made, demonstrated that the emulsion achieved present a rheological profile and stability conditions suitable for medicinal use cream.